We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$971M
AUM Growth
+$138M
Cap. Flow
+$87.1M
Cap. Flow %
8.98%
Top 10 Hldgs %
38.67%
Holding
181
New
15
Increased
73
Reduced
31
Closed
12

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$14.2M
2
CSCO icon
Cisco
CSCO
+$11.3M
3
AMZN icon
Amazon
AMZN
+$7.48M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$6.52M
5
SCHW
Charles Schwab
SCHW
+$5.93M

Sector Composition

Rank Sector Weight
1 Technology 35.34%
2 Financials 24.88%
3 Healthcare 12.23%
4 Communication Services 10.19%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
76
DaVita
DVA
$15.1B
$2.69M 0.28%
45,800
+16,400
+56% +$1.15M
ENS icon
77
EnerSys
ENS
$6.95B
$2.65M 0.27%
40,687
+2,750
+7% +$183K
SYK icon
78
Stryker
SYK
$127B
$2.65M 0.27%
22,950
-2,950
-11% -$344K
IPG
79
DELISTED
Interpublic Group of Companies
IPG
$2.64M 0.27%
117,920
-26,620
-18% -$612K
NOC icon
80
Northrop Grumman
NOC
$77B
$2.62M 0.27%
11,459
DGX icon
81
Quest Diagnostics
DGX
$25.1B
$2.61M 0.27%
32,000
+6,600
+26% +$554K
NBR icon
82
Nabors Industries
NBR
$1.23B
$2.6M 0.27%
4,374
-12
-0.3% -$5.91K
VLO icon
83
Valero Energy
VLO
$89.8B
$2.55M 0.26%
+42,995
New +$2.29M
SNY icon
84
Sanofi
SNY
$104B
$2.54M 0.26%
65,200
+3,400
+6% +$136K
JNJ icon
85
Johnson & Johnson
JNJ
$635B
$2.52M 0.26%
21,700
STJ
86
DELISTED
St Jude Medical
STJ
$2.45M 0.25%
31,500
UNH icon
87
UnitedHealth
UNH
$382B
$2.42M 0.25%
17,100
GSBC icon
88
Great Southern Bancorp
GSBC
$863M
$2.41M 0.25%
58,239
-2,221
-4% -$89.3K
CRL icon
89
Charles River Laboratories
CRL
$10.9B
$2.4M 0.25%
31,600
-1,300
-4% -$109K
WOOF
90
DELISTED
VCA Inc.
WOOF
$2.37M 0.24%
38,600
-8,700
-18% -$608K
CSRA
91
DELISTED
CSRA Inc.
CSRA
$2.29M 0.24%
91,431
+3,000
+3% +$77.4K
GNTX icon
92
Gentex
GNTX
$4.88B
$2.29M 0.24%
135,530
+20,550
+18% +$355K
MDT icon
93
Medtronic
MDT
$107B
$2.25M 0.23%
27,418
+4,751
+21% +$414K
BIIB icon
94
Biogen
BIIB
$29.9B
$2.23M 0.23%
7,950
+1,200
+18% +$355K
AET
95
DELISTED
Aetna Inc
AET
$2.16M 0.22%
20,160
AIZ icon
96
Assurant
AIZ
$13.7B
$2.12M 0.22%
26,300
+1,945
+8% +$170K
VVX icon
97
V2X
VVX
$2.62B
$1.97M 0.2%
117,202
+5,401
+5% +$162K
CSGS
98
DELISTED
CSG Systems International
CSGS
$1.84M 0.19%
48,299
+32,780
+211% +$1.37M
ENDP
99
DELISTED
Endo International plc
ENDP
$1.79M 0.18%
+95,700
New +$1.9M
CI icon
100
Cigna
CI
$76.6B
$1.66M 0.17%
14,000
-4,200
-23% -$548K

Similar funds

Oak Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Oak Associates held 181 positions worth $971M, up 17% from $833M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Oak Associates deployed $87.1M of net new capital in Q3 2016, opening 15 new positions and adding to 73 existing holdings. Its largest new stake was State Street: 216,980 shares worth $15.2M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was CR Bard Inc., an estimated $17M trimmed.

  • Oak Associates's largest Q3 2016 buy was State Street: 216,980 shares worth $15.2M.
  • Oak Associates added most to Cisco in Q3 2016, an estimated $11.3M increase.
  • Oak Associates's biggest Q3 2016 reduction was CR Bard Inc., cutting an estimated $17M.
  • Oak Associates fully exited EMC CORPORATION in Q3 2016, selling an estimated $4M.
  • Oak Associates's ten largest holdings make up 39% of its $971M portfolio in Q3 2016.
  • Oak Associates opened 15 new positions and closed 12 in Q3 2016.
  • Oak Associates's portfolio value rose 17% quarter-over-quarter to $971M.

Based on Oak Associates's 13F filing for Q3 2016, filed 9 Nov 2016.